FONGIT-Life with Dr. Igor Fisch
Date
10.04.2025 12:00 - 14:00
Location
Campus Biotech, Ch. des Mines 9, 1202 Genève
Register
Join us for an exclusive in-person lunchtime workshop with Igor Fisch, President of FONGIT and a seasoned entrepreneur in the life sciences industry. As the CEO and co-founder of NewBiologix—an innovative gene therapy start-up—and former CEO and co-founder of Selexis, a global leader in cell line development, Igor brings a wealth of experience in building and scaling biotech ventures. Don’t miss this opportunity to gain firsthand insights on what it takes to launch and grow a successful life sciences startup!
About the speaker:
Igor Fisch is Chair of FONGIT. Igor is also CEO and co-founder of NewBiologix, a start-up active in gene therapies. Formerly, he was CEO and co-founder of Selexis, a world-leading cell line development company. With a successful exit in 2017, Igor was instrumental in guiding Selexis to develop technologies that help biopharmaceutical companies manufacture biologic drugs such as monoclonal antibodies. Under his leadership, this resulted in 10 marketed products. He obtained his PhD at the University of Geneva and continued his postdoctoral studies under Nobel laureate, Prof. Sir Gregory Winter. Igor sits on the boards of Igyxos and Fluosphera.
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
